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Summary Using an indirect immunohistochemical technique on paraffin sections, employing a polyclonal
antibody to the acidic (placental) form of glutathione-S-transferase (GST), we have evaluated cytoplasmic and
nuclear staining in a series of 67 cervical biopsies including normal non neoplastic tissue, immature squamous
metaplasia, all grades of cervical intraepithelial neoplasia (CIN) and invasive carcinomas of keratinising and
non-keratinising types. No differences in cytoplasmic staining between the varied lesions studied were seen.
However, there were marked differences in nuclear staining. While normal non-neoplastic stratified squamous
epithelium showed weak staining of the lower one-third of the epithelium only, in immature squamous
metaplasia and in all grades of CIN there was intense nuclear staining in all layers of the epithelium. Invasive
carcinomas showed generally less intense nuclear staining than CIN lesions. Endocervical cell nuclei also
showed intense nuclear staining. These findings indicate that GST is of limited use as a marker of transforma-
tion in the human cervix uteri.
Neoplasia of the uterine cervix is a common disease which
can be detected and treated at an early stage in its evolution.
The importance of screening is likely to increase with the
rising incidence of cervical intraepithelial neoplasia (CIN)
and shift towards a younger population age group (Elliot et
al., 1989). However, cervical screening is a labour-intensive,
time-consuming process and errors occasionally occur
because of fatigue or because of the subjective nature of the
interpretation of cervical cytology (Spriggs & Boddington,
1980). A sensitive and specific marker of neoplastic cells
might reduce the subjectivity of the task and perhaps be
applied to an automated screening system (Sincock et al.,
1983).
Human papilloma virus (HPV) infection is thought to be
involved in the development of many, if not all, cases of
cervical neoplasia (Brescia et al., 1986; Young et al., 1989),
HPV types 6 and 11 being associated with benign lesions and
16 and 18 with invasive carcinoma (McCance, 1986). How-
ever, the cellular events associated with neoplastic transform-
ation are poorly understood. The study of the altered expres-
sion of a variety of products by neoplastic cells may help to
elucidate the process of malignant transformation.
Previous studies have examined the expression of a number
of potential markers of transformation, and studies on
cytokeratin have been of particular interest amongst these
(Morris et al., 1983; Fray et al., 1984). While normal cervical
stratified squamous epithelium expresses high molecular
weight cytokeratins, all non-keratinising invasive squamous
carcinomas and some cases of CIN3 express low-molecular
weight cytokeratins as well as those of high molecular weight
(Whittaker et al., 1989; Raju, 1988; Bobrow et al., 1986).
Using monoclonal antibody NCL-5D3, recognising
cytokeratins 8, 18 and 19 (Angus et al., 1987) we have
confirmed these observations (Angus et al., 1988). Thus,
there is a change in cytokeratin expression associated with
the development of in situ and invasive malignancy. The
expression of low molecular weight cytokeratins by these cells
appears to accompany the process of malignant transforma-
tion; possibly low molecular weight cytokeratins are appro-
priate for proliferating or mobile squamous cells. However,
since low molecular weight cytokeratins are expressed by
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only a proportion of cases of CIN3, and not at all by CINl
and CIN2, their detection is probably of limited use as a
diagnostic tool. HPV antigens demonstrated immunohisto-
chemically, which would appear to present attractive
possibilities in view of their proposed aetiologic role in
CIN, while expressed in CIN 1 and 2 lesions, are not found
in CIN 3 (Sterrett et al., 1987). Some workers find demons-
tration of the number of nucleolar organiser regions in
epithelial cells to be a useful marker of transformation (Egan
et al., 1988).
The cytosolic glutathione S-transferases (GST) are a group
of enzymes involved in the conjugation of glutathione to a
wide range of xenobiotics and as such are believed to be
responsible for the detoxification of a variety of substances
(Jakoby, 1978, 1980). They are classified according to their
iso-electric point into three groups, basic, acidic and neutral,
which differ in their gene locus, amino acid sequence, and
substrate specificity, and are immunologically distinct (Man-
nervik et al., 1985; Laisney et al., 1984; Jakoby, 1978). The
cellular role of the GSTs is a matter of speculation; a pos-
sible role in carcinogenesis has been suggested.
They may act by converting potential carcinogens to their
active forms (Seidegard et al., 1986). Additionally there is
evidence that they may have a role in inactivation of some
carcinogens (Clapper et al., 1987). GSTs have also been
implicated in the development of drug resistance in some
tumours by inactivating chemotherapeutic agents. Evidence
for this comes from work with drug resistant cell lines (Wang
& Tew, 1985; Robson et al., 1987) and also studies of tumour
biopsies which have suggested that those tumours which are
generally resistant to chemotherapy, for example colonic car-
cinomas, have high levels of acidic GST, whilst those
generally responsive, for example those of the head and neck,
have low levels (Clapper et al., 1987).
Shiratori et al. (1987) demonstrated increased expression of
acidic GST, both nuclear and cytoplasmic, in all grades of
CIN as well as invasive lesions, compared with absence of
expression in normal stratified squamous epithelium. This
group used a rabbit polyclonal antibody for immunohis-
tochemical evaluation of expression and they further demon-
strated enhanced v-H-ras gene product in many lesions show-
ing enhanced GST expression. Shiratori proposed that GST
was a potentially useful marker for pre-neoplasia of the
human cervix. The purpose of the present studies was to
evaluate this hyopothesis using a polyclonal antibody raised
in rabbits to GST purified from a human spleen.
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Materials and methods
Cases
Neutral buffered formalin-fixed, paraffin wax-embedded tis-
sue was retrieved from the files of Middlesbrough General
Hospital. The material studied consisted of seven normal
cervices from hysterectomy specimens, 11 colposcopic biop-
sies showing immature squamous metaplasia, seven each of
CINI, CIN2 and CIN3 from colposcopic biopsy specimens
and 28 invasive carcinomas, some of which were from cer-
vical punch biopsies (n = 18) while others were from
hysterectomy specimens (n = 10).
Routine diagnostic criteria were applied (Buckley et al.,
1982); briefly these are as follows: cases of immature
squamous metaplasia showed a multilayered epithelium with
no surface maturation, little intracytoplasmic glycogen and
associated mucinous columnar epithelial cells, usually on the
epithelial surface. In all cases of CIN, nuclear abnormalities
characteristic of neoplasia, such as nuclear enlargement,
hyperchromatism and pleomorphism, were present through-
out the full thickness of the epithelium, but there was no
invasion of the epithelial basement membrane. In many cases
there was cytoplasmic differentiation in the upper part of the
epithelium. Cases of CIN were graded according to the pro-
portion of the epithelial thickness occupied by
undifferentiated neoplastic cells of basaloid type. Thus, in
CIN I undifferentiated cells occupied the lower third or less
of the epithelium, in CIN II undifferentiated cells occupied
between one-third and two-thirds of the epithelium, while in
CIN III undifferentiated cells occupied more than two-thirds
of the epithelial thickness. Cases of invasive squamous car-
cinoma were those in which the neoplastic squamous
epithelial cells had invaded through the basement membrane
into the underlying stroma. The cases of invasive carcinoma
were subdivided into keratinising and non-keratinising types.
The cases of CIN were further classified according to the
presence or absence of koilocytosis. Koilocytes were defined
as epithelial cells showing prominent perinuclear cytoplasmic
clearing, thickened cell margins and hyperchromatic nuclei
with irregular outlines and uniformly distributed hetero-
chromatin (Ludwig et al., 1981).
Purification ofglutathione S-transferase
Acidic GST was obtained from the spleen of a patient with
chronic lymphocytic leukaemia and purified using affinity
chromatography and fast protein liquid chromatography
(FPLC) on Mono Q. (Mannervik & Guthenberg, 1981;
Habik & Jakoby, 1981). The enzyme isolated in this way has
similar substrate specificities, molecular weight on SDS-
PAGE and iso-electric point as the human pi form isolated
from placenta (manuscript in preparation).
Preparation ofantiserum
Polyclonal antiserum to the GST was raised in male New
Zealand white rabbits. Protein (150-200 tg) was injected
into the hind quarter intramuscularly on each occasion
initially with Freund's complete adjuvant. Subsequent mon-
thly injections used Freund's incomplete adjuvant. Antiserum
specificity and titre were assessed using both an ELISA tech-
nique and immunoblotting. The antiserum cross-reacts with
placental and platelet GST. No cross-reactions with basic
and neutral forms of GST isolated from human liver, or with
other cytosolic proteins, were seen at dilutions of 1 in 1,000
(ELISA, immunoblotting) and 1 in 100 (immunocytochemis-
try) (manuscript in preparation).
Immunohistochemical staining
The principles of the methods used have been described by
Burns (1979). Three jAm paraffin wax sections were cut from
the tissue blocks and mounted on lysine coated slides. The
sections were dried, dewaxed and rehydrated. After washing
with water the sections were immersed in TRIS buffered
saline for S min and then covered by normal swine serum
diluted 1 in 5 with TRIS buffered saline. After 10min the
excess swine serum was removed and replaced by the primary
anti-GST antibody at a dilution of I in 400. After overnight
incubation at 4°C the sections were rinsed twice in TRIS
buffered saline for 5min and swine anti-rabbit secondary
antibody (Dako) at a dilution of 1 in 20 applied. Following
incubation for 30 min at room temperature the sections were
washed in TRIS buffered saline and rabbit peroxidase-anti-
peroxidase antibody (Dako) applied at 1 in 50 dilution in
normal swine serum. After incubation for 30 min at room
temperature the sections were rinsed in TRIS buffered saline
and the peroxidase reaction developed using diaminobenzi-
dine solution (prepared by dissolving 80mg diaminobenzi-
dine in 100 ml of a 0.68 g1` solution of imidazole) with 1%
hydrogen peroxide. Sections were incubated with this solu-
tion for between 1 and 2 min and then thoroughly washed in
water, counterstained with haematoxylin and mounted. Tis-
sue from a carcinoma of the breast was used as a positive
control, while omission of primary and secondary antibodies
served as negative controls.
Scoring
The intensity of staining was graded as follows: (-) negative;
(+) positive; (+ +) strongly positive. The proportion of cells
showing staining was scored as follows: 1, 1-25%; 2,
26-50%, 3, 51-75%; 4, 76-100%.
The distribution of staining was assessed by scoring
separately the nuclear and cytoplasmic staining. Endocervical
epithelium as well as stratified squamous epithelium was
examined. The basal, parabasal, intermediate and superficial
layers of the stratified epithelium of the normal cervices,
immature squamous metaplasia and cases of CIN were
assessed separately, as were the koilocytes present in some of
the cases of CIN.
For each case, all relevant tissue on the sections was
examined and scored as above. Tables were constructed to
allow comparison of the number of cells stained and intensity
and distribution of staining in the different types of
epithelium.
Results
Koilocytosis was identified in six of the seven cases of CINI,
six of the seven cases of CIN2 and five of the seven cases of
CIN3. Of the invasive carcinomas, 22 were non-keratinising
while six were keratinising. Although there was some varia-
tion between individual cases, the pattern of cytoplasmic
staining was similar in normal stratified squamous cervical
epithelium, immature squamous metaplasia, all grades of
CIN and invasive carcinomas. In most cases, cytoplasmic
staining of moderate intensity (scored +) was seen in more
than 50% of cells. No differences in the pattern of cytoplas-
mic staining between the categories studied were identified.
However, marked differences in nuclear staining between
normal stratified squamous cervical epithelium, immature
squamous metaplasia, CIN and invasive carcinoma were
observed. Most of the normal cervices showed nuclear stain-
ing graded as + intensity of less than 25% ofcells, mainly in
the lower layers of the stratified squamous epithelium (Tables
I and II, Figure 1). In all grades of CIN, there was more
intense nuclear staining of a greater proportion of the cells
(Tables I and II), and staining of nuclei in the upper
epithelial layers was also noted (Figures 2-4). Immature
squamous metaplasia showed a nuclear staining pattern
similar to that of CIN. Nuclear staining in the invasive
carcinomas was variable, but in general was less intense than
in CIN, and in most cases less than 50% of the cells showed
nuclear staining. No differences in nuclear staining pattern
between non-keratinising and keratinising squamous car-
cinomas were found (Tables I and II). The koilocytes present
in many of the cases of CIN showed both cytoplasmic and616 B.J. RANDALL et al.
Table I Intensity of staining of neoplastic and non-neoplastic
squamous epithelium
Intensity of nuclear staining
+ + + Total
Normal 1 6 0 7
Immature squamous metaplasia 0 0 11 11
CIN I 0 1 6 7
CIN 2 0 0 7 7
CIN 3 0 0 7 7
Invasive squamous carcinoma
Non-keratinising 0 13 9 22
Keratinising 0 5 1 6
The numbers shown indicate the number of cases falling into each
staining intensity category.
Figure 3 Stratified squamous epithelium showing CIN 11.
Intense nuclear staining is seen in the upper one-third of the
epithelium, with much lighter staining of the flattened surface
layer and lower layers. Original magnification x 200.
a
Figure 1 Non-neoplastic cervical stratified squamous epithelium.
Note weak staining in the lower one-third of the epithelium.
Original magnification x 200.
b
Figure 2 Stratified squamous epithelium showing CIN l. Note
intense staining of nuclei in the lower one-third of the epithelium.
Original magnification x 200.
Figure 4 Stratified squamous epithelium showing CIN III.
Intense nuclear staining is seen in all layers, maximal in the upper
two-thirds. Original magnifications: a x 400; b x 200.
Table II The proportion of cells showing nuclear staining in normal and neoplastic
stratified squamous epithelium
Proportion of cells showing nuclear staining
0 1-25% 26-50% 51-75% 76- 100% Total
Normal 1 6 0 0 0 7
Immature squamous 0 0 6 2 3 ll
metaplasia
CIN I 0 3 3 1 0 7
CIN 2 0 1 5 1 0 7
CIN 3 0 0 4 3 0 7
Invasive squamous ca.
Non-keratinising 0 11 8 3 0 22
Keratinising 0 4 2 0 0 6
The numbers shown indicate the numbers of cases falling into each category.GLUTATHIONE S-TRANSFERASE IN THE HUMAN CERVIX 617
nuclear staining but this did not appear to differ in intensity
or distribution from that seen in the non-koilocytotic cells.
Where endocervical epithelium was present, all cases showed
nuclear staining (Figure 5).
Discussion
Although we have found an association between the develop-
ment ofcervical neoplasia and expression of GST, our results
differ from those of Shiratori et al. (1987), who found an
increase in both cytoplasmic and nuclear expression of GST
with increasing severity of neoplasia from CIN1 to invasive
carcinoma. In contrast, we found no differences in cytoplas-
mic staining, while nuclear staining was increased in all
grades of CIN, but not in invasive carcinomas. Unlike these
workers, we found no association between koilocytosis and
expression of GST.
The differences in these results may be due to either the
specificity of the primary antibody or the technical methods
used. Although both primary antibodies were shown to be
specific for acidic GST, Shiratori et al. (1987) used antiserum
raised to GST of placental origin, whereas our antiserum was
raised to GST derived from the spleen of a patient with
chronic lymphocytic leukaemia. Thus there may be minor
differences in the specificities of the antibodies which could
affect binding at some sites. Furthermore, while our tissues
were fixed in formalin, most of the specimens used by
Shiratori et al. (1987) had been fixed in 90% ethanol,
although a few of their cases were fixed in 10% formalin:
90% ethanol. Thus, differences in fixation may also account
for differences in the immunohistochemical staining patterns.
Indeed, Shiratori et al. reported that nuclear staining was
stronger in ethanol-fixed tissues than in formalin: ethanol
fixed tissues and it is possible therefore that fixation may also
affect cytoplasmic staining.
Finally, in this 'study a peroxidase-antiperoxidase method
was used, while Shiratori et al. used avidin-biotin-
peroxidase.
The role of GST in neoplastic transformation is not clear.
Our findings do not suggest that it is related to cell prolifera-
tion, since expression was less in the invasive carcinomas
than in the cases of CIN. Furthermore, GST expression was
often maximal in the upper epithelial layers in cases of CIN,
including CIN1, whereas proliferation would be expected to
be greatest in the lower layers.
GST may be involved in the process of carcinogenesis,
perhaps by carcinogen activation or inactivation (Wang &
Tew, 1985; Robson et al., 1987; Seidegard et al., 1986) or in
response to viral infection. This function may become
obsolete once malignant transformation has occurred,
explaining the decreased nuclear expression which we found
in invasive carcinomas.
Our studies indicate that GST would be of limited use as a
marker of cervical neoplasia in cervical cytology screening by
either conventional or automated methods. The increased
nuclear expression of GST was consistent, in that the inten-
increased ~ in al bu on:aeo;CN oee, enoeria
A.
incrasedsinells but onecasualosbe ofCNtowiever,y endocervical
cells visually in a cervical smear preparation, but an
automated process would require a second marker. For
example, nuclear GST positive cells could be evaluated for
DNA content (Millet et al., 1982), or endocervical cells dis-
counted by staining for an antibody specific for simple
epithelium. The expression of GST by immature squamous
metaplasia is particularly disappointing as this lesion may be
mistaken for CIN on both cytology and histology.
A further potential disadvantage of GST as a marker of
transformation is that it would possibly not detect invasive
carcinomas. This is not certain, however, as we have not yet
evaluated GST expression in exfoliated cells. Furthermore,
Shiratori et al. (1987) demonstrated enhanced expression in
invasive carcinoma as well as pre-invasive lesions.
Although GST may be of use in diagnostic cytology, it
seems likely that more specific markers of transformation,
such as oncogene or tumour suppressor gene nuclei acid or
protein (Spandidos & Anderson, 1989) may prove to be more
valuable in this area. As well as immunohistochemistry, tech-
niques such as in situ hybridisation, applied successfully to
detection of viral nucleic acid in cervical lesions (Burns et al.,
1987) have potential use.
In conclusion, GST shows lack of specificity for CIN and
possibly also lack of sensitivity for invasive carcinoma and
therefore is of little use as a marker of transformation in the
human cervix uteri.
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